C11orf71 Activators

C11orf71 engage in a variety of cellular signaling cascades to exert their modulatory effects on this protein. Forskolin, a labdane diterpene, directly stimulates adenylate cyclase resulting in a surge of cyclic AMP (cAMP) within the cell. This increase in cAMP levels activates protein kinase A (PKA), which can phosphorylate C11orf71, leading to its functional activation. Similarly, isoproterenol, a synthetic analog of epinephrine, binds to β-adrenergic receptors and triggers an increase in adenylate cyclase activity. This elevation in enzyme activity boosts cAMP production, subsequently activating PKA that then targets C11orf71 for phosphorylation. Another compound, Prostaglandin E2 (PGE2), operates through its EP receptor to raise intracellular cAMP levels, again engaging PKA in the phosphorylation process of C11orf71.

CAMP-mediated processes, there are other pathways that lead to the activation of C11orf71. Ionomycin, a calcium ionophore, raises intracellular calcium levels, which can activate calcium-dependent kinases capable of phosphorylating C11orf71. Phorbol 12-myristate 13-acetate (PMA) engages protein kinase C (PKC), a family of enzymes known to phosphorylate a broad array of cellular targets, including C11orf71. Epinephrine and dopamine, both catecholamines, bind to their respective receptors and similarly initiate adenylate cyclase activation, cAMP production, and PKA-mediated phosphorylation of C11orf71. Histamine, through the H2 receptor, and cholera toxin, by permanently activating the Gs alpha subunit, both enhance adenylate cyclase activity, leading to PKA activation and subsequent phosphorylation of C11orf71. Additionally, anisomycin, which is primarily a protein synthesis inhibitor, can activate stress-activated protein kinases such as JNK that might target C11orf71. Okadaic acid, through the inhibition of protein phosphatases, leads to an accumulation of phosphorylated proteins, possibly including C11orf71. Lastly, retinoic acid modulates various kinase signaling pathways, including MAPKs, which may phosphorylate and thereby activate C11orf71.